Colgate Announces 1st Quarter 2019 Results
Net income and Diluted earnings per share in first quarter 2019 were
Net income and Diluted earnings per share in first quarter 2018 were
Excluding charges resulting from the Global Growth and Efficiency
Program in both periods, Net income in first quarter 2019 was
Gross profit margin was 58.9% in first quarter 2019 versus 60.2% in first quarter 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Gross profit margin was 59.2% in first quarter 2019, a decrease of 110 basis points versus the year ago quarter as higher raw and packaging material costs, which included foreign exchange transaction costs, were partially offset by cost savings from the Company’s funding-the-growth initiatives and higher pricing.
Selling, general and administrative expenses were 35.1% of Net sales in
first quarter 2019 versus 34.8% of Net sales in first quarter 2018.
Excluding charges resulting from the Global Growth and Efficiency
Program in both periods, Selling, general and administrative expenses
increased by 30 basis points versus the year ago quarter to 35.0% of Net
sales in first quarter 2019 due to increased advertising investment
partially offset by lower overhead expenses, both as a percentage of Net
sales. On an absolute basis, worldwide advertising investment increased
3% to
Operating profit decreased to
Net cash provided by operations year to date was
“We believe our plans to accelerate growth are beginning to pay off, as the stronger organic sales growth we delivered in the quarter had a better balance between pricing and volume growth than we saw in the fourth quarter of 2018. This growth was led by our toothpaste and Hill's businesses.
“Advertising investment increased in absolute dollars and as a percent to sales versus first quarter 2018, with increases as a percent to sales in every division.
“Colgate’s leadership of the global toothpaste market continued during the quarter with our global market share at 41.7% year to date. Our global leadership in manual toothbrushes also continued with Colgate’s global market share in that category at 31.6% year to date.”
Mr. Wallace continued, “As we look ahead, based on current spot rates, we continue to expect 2019 net sales to be flat to up low-single-digits, with organic sales growth of 2% to 4% as we continue to plan for increased investment behind our brands, higher pricing and strong innovation, led by the relaunches of Colgate Total and Hill’s Science Diet and our continued focus on naturals.
“We are investing in expanding our portfolio offerings by bringing brands like elmex and meridol into new markets and by broadening our eCommerce offerings, building on our strong eCommerce growth in 2018. We are also continuing to increase our investment behind our professional skin care businesses, Elta MD and PCA Skin.
“On a GAAP basis, based on current spot rates, we expect gross margin expansion and a low-single-digit decline in earnings per share in 2019.
“Excluding charges resulting from the Global Growth and Efficiency Program in both 2018 and 2019, the charge related to U.S. tax reform in 2018 and the benefit from a foreign tax matter in 2018, based on current spot rates, we continue to plan for a year of gross margin expansion, increased advertising investment and a mid-single-digit decline in earnings per share.”
At
The following are comments about divisional performance for first quarter 2019 versus the year ago period. See attached Geographic Sales Analysis Percentage Changes and Segment Information tables for additional information on divisional net sales and operating profit.
North
Operating profit in
In the U.S., Colgate maintained leadership in the toothpaste category
during the quarter with its market share at 34.8% year to date.
Successful products include Colgate TotalSF, Colgate Optic
White Stain Fighter, Colgate Optic White Stain-Less White and Tom’s of
Products succeeding in other categories include Softsoap Gentle Wash body wash, Irish Spring 5-in-1 body wash, Fabuloso Complete liquid cleaner and Suavitel Complete fabric conditioner.
Latin
Operating profit in
Colgate maintained its toothpaste leadership in
Products succeeding in other categories include Colgate Total 12 and Colgate Periogard mouthwash, Protex Deep Clean and Palmolive Natureza Secreta bar soaps, Lady Speed Stick Clinical Complete and Speed Stick Clinical Complete spray deodorants, Axion dish liquid and Fabuloso Complete liquid cleaner.
Europe Net sales decreased 7.0% in first quarter 2019. Unit volume
increased 1.5%, pricing decreased 1.0% and foreign exchange was negative
7.5%. Volume gains were led by the
Operating profit in
Colgate maintained its toothpaste leadership in
Products succeeding in other categories include Sanex pump body lotions, Sanex, and Palmolive Clay body washes, Ajax Boost liquid cleaner and Soupline fabric conditioner.
Asia
Operating profit in
Colgate maintained its toothpaste leadership in the
Products succeeding in other categories include Colgate Slim Soft Advanced Volcanic Minerals and Colgate Slim Soft Flex Clean manual toothbrushes, Palmolive Skin Therapy bar soap, Palmolive Luminous Oils shower gel and Softlan Divine Pleasures fabric conditioner.
Operating profit in
Colgate maintained its toothpaste leadership in
Hill's Pet Nutrition (15% of Company Sales)
Hill’s Net sales increased 3.0% during first quarter 2019. Unit volume
increased 2.0%, pricing increased 4.0% and foreign exchange was negative
3.0%. Volume gains in
Hill’s Operating profit was even with the year ago quarter, while as a percentage of Net sales it decreased 80 basis points to 27.3% of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit and an increase in Selling, general and administrative expenses, both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs, partially offset by cost savings from the Company’s funding-the-growth initiatives and higher pricing. This increase in Selling, general and administrative expenses was due to increased advertising investment, partially offset by lower overhead expenses.
Successful products contributing to sales in
Successful products contributing to sales internationally include Hill’s Prescription Diet k/d + Mobility, Hill’s Prescription Diet Metabolic + Urinary, Hill's Prescription Diet Stews and Hill's Science Diet Perfect Weight.
***
About
Market Share Information
Management uses market share information as a key indicator to monitor
business health and performance. References to market share in this
press release are based on a combination of consumption and market share
data provided by third-party vendors, primarily Nielsen, and internal
estimates. All market share references represent the percentage of the
dollar value of sales of our products, relative to all product sales in
the category in the countries in which the Company competes and
purchases data (excluding
Market share data is subject to limitations on the availability of
up-to-date information. In particular, market share data is currently
not generally available for certain retail channels, such as eCommerce
or certain discounters. The Company measures year-to-date market shares
from
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast may contain forward-looking
statements (as that term is defined in the U.S. Private Securities
Litigation Reform Act of 1995 or by the
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial measures used in this earnings release and/or the related webcast:
This release discusses Net sales growth (GAAP) and organic sales growth,
which is Net sales growth excluding the impact of foreign exchange,
acquisitions and divestments (non-GAAP). Management believes the organic
sales growth measure provides investors and analysts with useful
supplemental information regarding the Company’s underlying sales trends
by presenting sales growth excluding the external factor of foreign
exchange as well as the impact from acquisitions and divestments. See
“Geographic Sales Analysis Percentage Changes” for the three months
ended
To supplement Colgate’s Condensed Consolidated Statements of Income
presented in accordance with GAAP, the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Worldwide
Gross profit, Gross profit margin, Selling, general and administrative
expenses, Selling, general and administrative expenses as a percentage
of Net sales, Other (income) expense, net, Operating profit, Operating
profit margin, Non-service related postretirement costs, Effective
income tax rate, Net income attributable to
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as Net cash provided
by operations less Capital expenditures. As management uses this measure
to evaluate the Company’s ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is a non-GAAP measure
and may not be comparable to similarly titled measures reported by other
companies. See “Condensed Consolidated Statements of Cash Flows” for the
three months ended
(See attached tables for first quarter results.)
Table 1 | ||||||||
Colgate-Palmolive Company | ||||||||
Condensed Consolidated Statements of Income | ||||||||
For the Three Months Ended March 31, 2019 and 2018 | ||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||
2019 | 2018 | |||||||
Net sales | $ | 3,884 | $ | 4,002 | ||||
Cost of sales | 1,597 | 1,594 | ||||||
Gross profit | 2,287 | 2,408 | ||||||
Gross profit margin | 58.9 | % | 60.2 | % | ||||
Selling, general and administrative expenses | 1,365 | 1,392 | ||||||
Other (income) expense, net | 43 | 33 | ||||||
Operating profit | 879 | 983 | ||||||
Operating profit margin | 22.6 | % | 24.6 | % | ||||
Non-service related postretirement costs | 25 | 24 | ||||||
Interest (income) expense, net | 40 | 35 | ||||||
Income before income taxes | 814 | 924 | ||||||
Provision for income taxes | 214 | 246 | ||||||
Effective tax rate | 26.3 | % | 26.6 | % | ||||
Net income including noncontrolling interests | 600 | 678 | ||||||
Less: Net income attributable to noncontrolling interests | 40 | 44 | ||||||
Net income attributable to Colgate-Palmolive Company | $ | 560 | $ | 634 | ||||
Earnings per common share | ||||||||
Basic | $ | 0.65 | $ | 0.72 | ||||
Diluted | $ | 0.65 | $ | 0.72 | ||||
Average common shares outstanding | ||||||||
Basic | 862.0 | 875.4 | ||||||
Diluted | 863.2 | 879.9 | ||||||
Table 2 | |||||||||||||
Colgate-Palmolive Company | |||||||||||||
Condensed Consolidated Balance Sheets | |||||||||||||
As of March 31, 2019, December 31, 2018 and March 31, 2018 | |||||||||||||
(Dollars in Millions) (Unaudited) | |||||||||||||
March 31, | December 31, | March 31, | |||||||||||
2019 | 2018 | 2018 | |||||||||||
Cash and cash equivalents | $ | 843 | $ | 726 | $ | 851 | |||||||
Receivables, net | 1,547 | 1,400 | 1,644 | ||||||||||
Inventories | 1,278 | 1,250 | 1,312 | ||||||||||
Other current assets | 465 | 417 | 485 | ||||||||||
Property, plant and equipment, net | 3,821 | 3,881 | 4,087 | ||||||||||
Other assets, including goodwill and intangibles | 4,929 | 4,487 | 4,765 | ||||||||||
Total assets | $ | 12,883 | $ | 12,161 | $ | 13,144 | |||||||
Total debt | $ | 6,661 | $ | 6,366 | $ | 6,709 | |||||||
Other current liabilities | 3,859 | 3,329 | 3,821 | ||||||||||
Other non-current liabilities | 2,573 | 2,269 | 2,513 | ||||||||||
Total liabilities | 13,093 | 11,964 | 13,043 | ||||||||||
Total Colgate-Palmolive Company shareholders’ equity | (552 | ) | (102 | ) | (249 | ) | |||||||
Noncontrolling interests | 342 | 299 | 350 | ||||||||||
Total liabilities and equity | $ | 12,883 | $ | 12,161 | $ | 13,144 | |||||||
Supplemental Balance Sheet Information | |||||||||||||
Debt less cash, cash equivalents and marketable securities(1) | $ | 5,781 | $ | 5,630 | $ | 5,803 | |||||||
Working capital % of sales | (3.9 | )% | (1.7 | )% | (2.7 | )% | |||||||
Note: |
(1) Marketable securities of $37, $10 and $55 as of March 31, 2019, December 31, 2018 and March 31, 2018, respectively, are included in Other current assets. |
Table 3 | |||||||||
Colgate-Palmolive Company | |||||||||
Condensed Consolidated Statements of Cash Flows | |||||||||
For the Three Months Ended March 31, 2019 and 2018 | |||||||||
(Dollars in Millions) (Unaudited) | |||||||||
2019 | 2018 | ||||||||
Operating Activities | |||||||||
Net income including noncontrolling interests | $ | 600 | $ | 678 | |||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | |||||||||
Depreciation and amortization | 128 | 129 | |||||||
Restructuring and termination benefits, net of cash | 5 | (25 | ) | ||||||
Stock-based compensation expense | 17 | 28 | |||||||
Deferred income taxes | 53 | 13 | |||||||
Voluntary benefit plan contributions | (102 | ) | — | ||||||
Cash effects of changes in: | |||||||||
Receivables | (145 | ) | (211 | ) | |||||
Inventories | (32 | ) | (33 | ) | |||||
Accounts payable and other accruals | 44 | 33 | |||||||
Other non-current assets and liabilities | 37 | 4 | |||||||
Net cash provided by operations | 605 | 616 | |||||||
Investing Activities | |||||||||
Capital expenditures | (71 | ) | (118 | ) | |||||
Purchases of marketable securities and investments | (27 | ) | (38 | ) | |||||
Payment for acquisitions, net of cash acquired | — | (727 | ) | ||||||
Other | — | 2 | |||||||
Net cash used in investing activities | (98 | ) | (881 | ) | |||||
Financing Activities | |||||||||
Principal payments on debt | (1,774 | ) | (2,079 | ) | |||||
Proceeds from issuance of debt | 2,076 | 2,226 | |||||||
Dividends paid | (366 | ) | (352 | ) | |||||
Purchases of treasury shares | (399 | ) | (351 | ) | |||||
Proceeds from exercise of stock options | 71 | 119 | |||||||
Net cash used in financing activities | (392 | ) | (437 | ) | |||||
Effect of exchange rate changes on Cash and cash equivalents | 2 | 18 | |||||||
Net increase (decrease) in Cash and cash equivalents | 117 | (684 | ) | ||||||
Cash and cash equivalents at beginning of the period | 726 | 1,535 | |||||||
Cash and cash equivalents at end of the period | $ | 843 | $ | 851 | |||||
Supplemental Cash Flow Information | |||||||||
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) | |||||||||
Net cash provided by operations | $ | 605 | $ | 616 | |||||
Less: Capital expenditures | (71 | ) | (118 | ) | |||||
Free cash flow before dividends | $ | 534 | $ | 498 | |||||
Income taxes paid | $ | 149 | $ | 163 | |||||
Table 4 | |||||||||
Colgate-Palmolive Company | |||||||||
Segment Information | |||||||||
For the Three Months Ended March 31, 2019 and 2018 | |||||||||
(Dollars in Millions) (Unaudited) | |||||||||
2019 | 2018 | ||||||||
Net Sales | |||||||||
Oral, Personal and Home Care | |||||||||
North America | $ | 853 | $ | 827 | |||||
Latin America | 889 | 929 | |||||||
Europe | 602 | 648 | |||||||
Asia Pacific | 700 | 759 | |||||||
Africa/Eurasia | 240 | 255 | |||||||
Total Oral, Personal and Home Care | 3,284 | 3,418 | |||||||
Pet Nutrition | 600 | 584 | |||||||
Total Net Sales | $ | 3,884 | $ | 4,002 | |||||
2019 | 2018 | ||||||||
Operating Profit | |||||||||
Oral, Personal and Home Care | |||||||||
North America | $ | 249 | $ | 257 | |||||
Latin America | 232 | 273 | |||||||
Europe | 151 | 162 | |||||||
Asia Pacific | 189 | 226 | |||||||
Africa/Eurasia | 46 | 50 | |||||||
Total Oral, Personal and Home Care | 867 | 968 | |||||||
Pet Nutrition | 164 | 164 | |||||||
Corporate(1) | (152 | ) | (149 | ) | |||||
Total Operating Profit | $ | 879 | $ | 983 |
Note: |
(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. Corporate Operating profit (loss) for the three months ended March 31, 2019 includes charges of $28 related to the Global Growth and Efficiency Program. Corporate Operating profit (loss) for the three months ended March 31, 2018 includes charges of $24 related to the Global Growth and Efficiency Program. |
Table 5 | |||||||||||||||||||||
Colgate-Palmolive Company | |||||||||||||||||||||
Geographic Sales Analysis Percentage Changes | |||||||||||||||||||||
For the Three Months Ended March 31, 2019 vs. 2018 | |||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||
COMPONENTS OF SALES CHANGE | |||||||||||||||||||||
Pricing | |||||||||||||||||||||
Coupons | |||||||||||||||||||||
Sales | Consumer & | ||||||||||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | |||||||||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Volume |
Incentives |
Exchange |
||||||||||||||
Total Company | (3.0 | )% | 3.0 | % | 1.0 | % | 1.0 | % | 1.0 | % | 2.0 | % | (6.0 | )% | |||||||
Europe | (7.0 | )% | 0.5 | % | 1.5 | % | 1.5 | % | 1.5 | % | (1.0 | )% | (7.5 | )% | |||||||
Latin America | (4.5 | )% | 6.0 | % | 2.5 | % | 2.5 | % | 2.5 | % | 3.5 | % | (10.5 | )% | |||||||
Asia Pacific | (8.0 | )% | (2.5 | )% | (2.5 | )% | (2.5 | )% | (2.5 | )% | — | % | (5.5 | )% | |||||||
Africa/Eurasia | (6.0 | )% | 7.0 | % | — | % | — | % | — | % | 7.0 | % | (13.0 | )% | |||||||
Total International | (6.0 | )% | 2.0 | % | 0.5 | % | 0.5 | % | 0.5 | % | 1.5 | % | (8.0 | )% | |||||||
North America | 3.0 | % | 3.5 | % | 2.0 | % | 2.0 | % | 2.0 | % | 1.5 | % | (0.5 | )% | |||||||
Total CP Products | (4.0 | )% | 2.5 | % | 1.0 | % | 1.0 | % | 1.0 | % | 1.5 | % | (6.5 | )% | |||||||
Hill’s | 3.0 | % | 6.0 | % | 2.0 | % | 2.0 | % | 2.0 | % | 4.0 | % | (3.0 | )% | |||||||
Emerging Markets(1) | (5.5 | )% | 3.0 | % | — | % | — | % | — | % | 3.0 | % | (8.5 | )% | |||||||
Developed Markets | (0.5 | )% | 3.0 | % | 2.0 | % | 2.0 | % | 2.0 | % |
1.0 |
% | (3.5 | )% |
Note: |
(1) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe. |
Table 6 | |||||||||||||||||
Colgate-Palmolive Company | |||||||||||||||||
Non-GAAP Reconciliations | |||||||||||||||||
For the Three Months Ended March 31, 2019 and 2018 | |||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||||||
Gross Profit | 2019 | 2018 | |||||||||||||||
Gross profit, GAAP | $ | 2,287 | $ | 2,408 | |||||||||||||
Global Growth and Efficiency Program | 11 | 6 | |||||||||||||||
Gross profit, non-GAAP | $ | 2,298 | $ | 2,414 | |||||||||||||
Basis Point | |||||||||||||||||
Gross Profit Margin | 2019 | 2018 | Change | ||||||||||||||
Gross profit margin, GAAP | 58.9 | % | 60.2 | % | (130 | ) | |||||||||||
Global Growth and Efficiency Program | 0.3 | % | 0.1 | % | |||||||||||||
Gross profit margin, non-GAAP | 59.2 | % | 60.3 | % | (110 | ) | |||||||||||
Selling, General and Administrative Expenses | 2019 | 2018 | |||||||||||||||
Selling, general and administrative expenses, GAAP | $ | 1,365 | $ | 1,392 | |||||||||||||
Global Growth and Efficiency Program | (4 | ) | (5 | ) | |||||||||||||
Selling, general and administrative expenses, non-GAAP | $ | 1,361 | $ | 1,387 | |||||||||||||
Basis Point | |||||||||||||||||
Selling, General and Administrative Expenses as a Percentage of Net Sales | 2019 | 2018 | Change | ||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 35.1 | % | 34.8 | % | 30 | ||||||||||||
Global Growth and Efficiency Program | (0.1 | )% | (0.1 | )% | |||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 35.0 | % | 34.7 | % | 30 | ||||||||||||
Other (Income) Expense, Net | 2019 | 2018 | |||||||||||||||
Other (income) expense, net, GAAP | $ | 43 | $ | 33 | |||||||||||||
Global Growth and Efficiency Program | (13 | ) | (13 | ) | |||||||||||||
Other (income) expense, net, non-GAAP | $ | 30 | $ | 20 | |||||||||||||
Operating Profit | 2019 | 2018 | % Change | ||||||||||||||
Operating profit, GAAP | $ | 879 | $ | 983 | (11)% | ||||||||||||
Global Growth and Efficiency Program | 28 | 24 | |||||||||||||||
Operating profit, non-GAAP | $ | 907 | $ | 1,007 | (10)% | ||||||||||||
Basis Point | |||||||||||||||||
Operating Profit Margin | 2019 | 2018 | Change | ||||||||||||||
Operating profit margin, GAAP | 22.6 | % | 24.6 | % | (200 | ) | |||||||||||
Global Growth and Efficiency Program | 0.8 | % | 0.6 | % | |||||||||||||
Operating profit margin, non-GAAP | 23.4 | % | 25.2 | % | (180 | ) | |||||||||||
Non-Service Related Postretirement Costs | 2019 | 2018 | |||||||||||||||
Non-service related postretirement costs, GAAP | $ | 25 | $ | 24 | |||||||||||||
Global Growth and Efficiency Program | (1 | ) | (4 | ) | |||||||||||||
Non-service related postretirement costs, non-GAAP | $ | 24 | $ | 20 | |||||||||||||
Table 6 | |||||||||||||||||||||||
Continued | |||||||||||||||||||||||
Colgate-Palmolive Company | |||||||||||||||||||||||
Non-GAAP Reconciliations | |||||||||||||||||||||||
For the Three Months Ended March 31, 2019 and 2018 | |||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||||||||||||
2019 | |||||||||||||||||||||||
Income Before Income Taxes |
Provision For Income Taxes(1) |
Net Income Including Noncontrolling Interests |
Net Income Attributable To Colgate- Palmolive Company |
Effective Income Tax Rate(2) |
Diluted Earnings Per Share |
||||||||||||||||||
As Reported GAAP | $ | 814 | $ | 214 | $ | 600 | $ | 560 | 26.3 | % | $ | 0.65 | |||||||||||
Global Growth and Efficiency Program | 29 | 7 | 22 | 22 | (0.1 | )% | 0.02 | ||||||||||||||||
Non-GAAP | $ | 843 | $ | 221 | $ | 622 | $ | 582 | 26.2 | % | $ | 0.67 | |||||||||||
2018 | |||||||||||||||||||||||
Income Before Income Taxes |
Provision For Income Taxes(1) |
Net Income Including Noncontrolling Interests |
Net Income Attributable To Colgate- Palmolive Company |
Effective Income Tax Rate(2) |
Diluted Earnings Per Share |
||||||||||||||||||
As Reported GAAP | $ | 924 | $ | 246 | $ | 678 | $ | 634 | 26.6 | % | $ | 0.72 | |||||||||||
Global Growth and Efficiency Program | 28 | 8 | 20 | 20 | 0.1 | % | 0.02 | ||||||||||||||||
Non-GAAP | $ | 952 | $ | 254 | $ | 698 | $ | 654 | 26.7 | % | $ | 0.74 | |||||||||||
The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding. |
Notes: |
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20190426005070/en/
Source:
John Faucher 212-310-3653
Hope Spiller 212-310-2291